Yoplait Report issue

For profit
Founded: Boulogne France (1965)
Status: Acquired by General Mills Inc. (2011)

Organization Overview

First Clinical Trial
2014
NCT02534064
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Yoplait France SAS

Active Ingredients

Drugs in Other Trials (2)

calcium (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2